These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8674146)

  • 21. Aspirin Induced Adverse Effects on the Small and Large Intestine.
    Pavlidis P; Bjarnason I
    Curr Pharm Des; 2015; 21(35):5089-93. PubMed ID: 26369683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mitochondrial damage: a possible mechanism of the "topical" phase of NSAID induced injury to the rat intestine.
    Somasundaram S; Rafi S; Hayllar J; Sigthorsson G; Jacob M; Price AB; Macpherson A; Mahmod T; Scott D; Wrigglesworth JM; Bjarnason I
    Gut; 1997 Sep; 41(3):344-53. PubMed ID: 9378390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of polyacrylic acid polymers on small-intestinal function and permeability changes caused by indomethacin.
    Bjarnason I; Smethurst P; Levi AJ; Menzies IS; Peters TJ
    Scand J Gastroenterol; 1991 Jul; 26(7):685-8. PubMed ID: 1896808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Small bowel permeability--a variable effect of NSAIDS.
    Choi VM; Coates JE; Chooi J; Thomson AB; Russell AS
    Clin Invest Med; 1995 Oct; 18(5):357-61. PubMed ID: 8529318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Small bowel injuries due to nonsteroidal anti-inflammatory drugs and antiplatelet therapy. Approaches to prevention and treatment].
    Drapkina OM; Korneeva ON
    Ter Arkh; 2016; 88(12):133-139. PubMed ID: 28635889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-administration of the health food supplement, bovine colostrum, reduces the acute non-steroidal anti-inflammatory drug-induced increase in intestinal permeability.
    Playford RJ; MacDonald CE; Calnan DP; Floyd DN; Podas T; Johnson W; Wicks AC; Bashir O; Marchbank T
    Clin Sci (Lond); 2001 Jun; 100(6):627-33. PubMed ID: 11352778
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the intestinal toxicity of celecoxib, a selective COX-2 inhibitor, and indomethacin in the experimental rat.
    Tibble JA; Sigthorsson G; Foster R; Bjarnason I
    Scand J Gastroenterol; 2000 Aug; 35(8):802-7. PubMed ID: 10994617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of non-steroidal anti-inflammatory drugs and prostaglandins on the permeability of the human small intestine.
    Bjarnason I; Williams P; Smethurst P; Peters TJ; Levi AJ
    Gut; 1986 Nov; 27(11):1292-7. PubMed ID: 3466837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enantiomers of flurbiprofen can distinguish key pathophysiological steps of NSAID enteropathy in the rat.
    Mahmud T; Somasundaram S; Sigthorsson G; Simpson RJ; Rafi S; Foster R; Tavares IA; Roseth A; Hutt AJ; Jacob M; Pacy J; Scott DL; Wrigglesworth JM; Bjarnason I
    Gut; 1998 Dec; 43(6):775-82. PubMed ID: 9824604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nonsteroidal anti-inflammatory drug enteropathy in rats: role of permeability, bacteria, and enterohepatic circulation.
    Reuter BK; Davies NM; Wallace JL
    Gastroenterology; 1997 Jan; 112(1):109-17. PubMed ID: 8978349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determining small bowel integrity following drug treatment.
    Smale S; Bjarnason I
    Br J Clin Pharmacol; 2003 Sep; 56(3):284-91. PubMed ID: 12919176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of non-steroidal anti-inflammatory drugs on the methotrexate transport in rat small intestine.
    Sosogi A; Gao F; Tomimatsu T; Hirata K; Horie T
    Scand J Gastroenterol; 2003 Jan; 38(1):43-9. PubMed ID: 12608463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonsteroidal anti-inflammatory drug-induced enteropathy: case discussion and review of the literature.
    Kwo PY; Tremaine WJ
    Mayo Clin Proc; 1995 Jan; 70(1):55-61. PubMed ID: 7808053
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intestinal toxicity of non-steroidal anti-inflammatory drugs.
    Bjarnason I; Macpherson AJ
    Pharmacol Ther; 1994; 62(1-2):145-57. PubMed ID: 7991640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NSAIDs and the small bowel.
    Tai FWD; McAlindon ME
    Curr Opin Gastroenterol; 2018 May; 34(3):175-182. PubMed ID: 29438118
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study.
    Maiden L; Thjodleifsson B; Seigal A; Bjarnason II; Scott D; Birgisson S; Bjarnason I
    Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1040-5. PubMed ID: 17625980
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early pathogenic events in NSAID-induced gastrointestinal damage.
    Bjarnason I; Hayllar J
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():19-22. PubMed ID: 9032577
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of mitochondria-derived reactive oxygen species in the pathogenesis of non-steroidal anti-inflammatory drug-induced small intestinal injury.
    Handa O; Majima A; Onozawa Y; Horie H; Uehara Y; Fukui A; Omatsu T; Naito Y; Yoshikawa T
    Free Radic Res; 2014 Sep; 48(9):1095-9. PubMed ID: 24870068
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of NSAID/aspirin-induced small intestinal damage by GI-sparing NSAIDs, anti-ulcer drugs and food constituents.
    Satoh H; Takeuchi K
    Curr Med Chem; 2012; 19(1):82-9. PubMed ID: 22300080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacologic targeting or genetic deletion of mitochondrial cyclophilin D protects from NSAID-induced small intestinal ulceration in mice.
    LoGuidice A; Ramirez-Alcantara V; Proli A; Gavillet B; Boelsterli UA
    Toxicol Sci; 2010 Nov; 118(1):276-85. PubMed ID: 20668000
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.